NASDAQ | ETF
The fund normally invests at least 80% of assets in securities of disruptive medicine companies.
Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers.
Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 5.40% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.84% |
| VEEV | Veeva Systems Inc Class A | Healthcare | Health Information Services | 3.54% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.52% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 3.32% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 3.20% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 3.13% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 3.13% |
| WAY | Waystar Holding Corp. Common Stock | Healthcare | Health Information Services | 3.12% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 3.07% |
| UCB | UCB SA | Healthcare | Biotechnology | 2.93% |
| PEN | Penumbra Inc | Healthcare | Medical Devices | 2.84% |
| MASI | Masimo Corporation | Healthcare | Medical Devices | 2.63% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 2.54% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 2.50% |
| DIM | Sartorius Stedim Biotech SA | Healthcare | Medical Instruments & Supplies | 2.32% |
| DXCM | DexCom Inc | Healthcare | Medical Devices | 1.91% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 1.89% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 1.88% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 1.83% |